| NCT06590090 | Natrunix in Combination With Methotrexate for Rheumatoid Arthritis Treatment | NOT_YET_RECRUITING | PHASE2 | 2025-07-15 | 2026-03-15 | 2026-01-15 |
| NCT06526377 | Natrunix in HLA-B27 Positive Subjects With Axial Spondyloarthritis | NOT_YET_RECRUITING | PHASE2 | 2024-08-15 | 2025-04-30 | 2025-02-28 |
| NCT05363891 | Natrunix or Placebo in Combination With Methotrexate in Rheumatoid Arthritis | COMPLETED | PHASE2 | 2023-08-08 | 2024-10-31 | 2024-10-31 |
| NCT05098080 | Hutrukin to Analyze Safety and PK in Healthy Volunteers | COMPLETED | PHASE1 | 2023-04-10 | 2024-04-05 | 2023-10-24 |
| NCT05363917 | Natrunix Versus Methotrexate in Rheumatoid Arthritis | UNKNOWN | PHASE2 | 2022-06-15 | 2023-02-15 | 2022-12-15 |
| NCT05099510 | Natrunix Safety PK Study in Healthy Volunteers | UNKNOWN | PHASE1 | 2022-01-19 | 2022-06-15 | 2022-05-01 |
| NCT04825288 | XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2021-05-27 | 2025-06-10 | 2023-10-26 |
| NCT02357966 | Safety & Efficacy of True Human Antibody, 514G3, in Staphylococcus Aureus Bacteremia Hospitalized Subjects. | COMPLETED | PHASE1, PHASE2 | 2015-05 | 2016-12 | 2016-12 |